How Coronavirus Could Slow Down The U.S. Drug Supply

The video discusses the reliance of the US drug supply on overseas factories, particularly in China and India, for active pharmaceutical ingredients (APIs). It highlights current drug shortages in the US, exacerbated by the coronavirus pandemic, which affects the supply chain. The FDA is aware of potential disruptions and has contacted manufacturers to report any anticipated issues. The video also explores the impact of shortages on drug prices and legislative efforts to require API manufacturers to report shortages. Experts warn of potential life-threatening consequences if specific drugs become unavailable.

What legislative measures have been proposed to address drug shortages in the US?

What challenges do patients face when specific medications are in short supply?